13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:22:48 UTC, with 78 holding rows worth $159,374,182.
- Accession
- 0001440771-26-000027
- Filer
- CIK 1440771
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 78 entries on the cover page, a total value of $159,374,182 stated on the cover page (in dollars after the unit check, H1), rows summing to $159,374,182 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,042,775 | $24,494,339 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 2,786,249 | $11,256,446 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 971,622 | $7,772,976 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 700,000 | $7,021,000 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 110,000 | $6,659,950 | dollars as filed | |
| ELOXX PHARMACEUTICALS INC | 29014R301 | COM NEW | 381,977 | $5,848,068 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 40,000 | $5,600,000 | dollars as filed | call |
| ADMA BIOLOGICS INC | 000899104 | COM | 400,000 | $5,200,000 | dollars as filed | call |
| EVOLUS INC | 30052C107 | COM | 500,000 | $5,000,000 | dollars as filed | call |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 150,000 | $4,500,000 | dollars as filed | call |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 50,000 | $4,250,000 | dollars as filed | call |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 40,000 | $4,200,000 | dollars as filed | call |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 455,058 | $3,866,320 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 377,429 | $3,621,431 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 100,000 | $3,585,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 210,000 | $3,156,300 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 100,000 | $3,000,000 | dollars as filed | call |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 710,266 | $2,990,220 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 200,000 | $2,600,000 | dollars as filed | call |
| Boston Scientific Corporation | 101137107 | COM | 55,000 | $2,400,750 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 964,900 | $2,064,886 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 350,877 | $1,866,666 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 189,092 | $1,711,283 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 689,000 | $1,605,370 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 300,000 | $1,500,000 | dollars as filed | call |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 282,016 | $1,480,584 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 44,100 | $1,419,138 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 200,000 | $1,400,000 | dollars as filed | call |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 749,028 | $1,378,212 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 2,774,234 | $1,367,697 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 188,201 | $1,343,755 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 647,285 | $1,330,171 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 100,000 | $1,250,000 | dollars as filed | call |
| OKYO PHARMA LTD | G6724L116 | SHS NEW | 914,367 | $1,179,533 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 252,434 | $1,151,099 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 588,000 | $1,111,320 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 100,000 | $1,100,000 | dollars as filed | call |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 100,000 | $1,097,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 520,000 | $998,400 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 676,973 | $940,992 | dollars as filed | |
| IN8BIO INC | 45674E208 | COM NEW | 697,852 | $928,143 | dollars as filed | |
| Gossamer Bio, Inc. | 38341P201 | Common Stock, $0.0001 par value per share | 63,039 | $747,012 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 20,000 | $743,800 | dollars as filed | |
| AZITRA INC | 05479L302 | COM NEW | 5,227,438 | $719,295 | dollars as filed | |
| FEMASYS INC | 31447E204 | COM NEW | 326,770 | $705,823 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 254,759 | $705,682 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 60,000 | $702,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 95,000 | $647,900 | dollars as filed | |
| AEON BIOPHARMA INC | 00791X209 | COM | 2,125,748 | $637,724 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 85,000 | $628,150 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 220,000 | $598,400 | dollars as filed | |
| SINTX TECHNOLOGIES INC | 829392703 | COM NEW | 233,936 | $521,677 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 18,998 | $500,407 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 98,147 | $475,031 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 787,269 | $469,370 | dollars as filed | |
| CalciMedica Inc | 38942Q301 | COM | 278,680 | $451,462 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 414,903 | $448,095 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 162,818 | $443,679 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 150,000 | $435,000 | dollars as filed | |
| NERVGEN PHARMA CORP | 64082X203 | COM | 200,000 | $382,000 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 40,000 | $364,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 88,108 | $279,302 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 57,663 | $264,097 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 31,200 | $258,024 | dollars as filed | |
| QT IMAGING HLDGS INC | 746962307 | COM | 100,000 | $254,500 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 224,881 | $251,867 | dollars as filed | |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 39,942 | $211,693 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 110,479 | $211,015 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 55,000 | $179,850 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 51,000 | $174,420 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 20,000 | $153,400 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 52,547 | $131,893 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 10,000 | $114,700 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 33,842 | $97,803 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 11,948 | $84,711 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 49,468 | $54,415 | dollars as filed | |
| EVAXION AS | 29970R303 | SPONSORED ADS | 16,566 | $54,336 | dollars as filed | |
| GERON CORP | 374163103 | COM | 20,000 | $24,600 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001440771-26-000027 | this filing | 2026-11-13 |